University of Minnesota cancer researchers readying intro of new molecular imaging technology

Advancements in molecular imaging technology - capable of “seeing” a patient’s biochemistry down to the cellular level - will likely play a big role in the personalized cancer treatments of the future, and a University of Minnesota bioengineering lab is preparing to introduce what could be a vital new product in the field.

One of the great promises of molecular imaging technology (formerly called nuclear medicine) is its ability to allow doctors to zero in on the minute characteristics of cancerous cells and thus detect the presence of the disease at an extremely early stage. Read more.